Quansheng Zhou

4.6k citations
89 papers · 3.7k indexed · h-index 37

Quansheng Zhou

89 papers receiving 3.7k citations

Peers

Quansheng Zhou
Comparison fields: 5 of 115
  • Immunology 871
  • Cancer Research 519
  • Molecular Biology 2.3k
  • Pharmacology 215
  • Oncology 640
Replace Michitaka Ozaki with:
Michitaka Ozaki Japan
Salvatore Papa United States
You Mie Lee South Korea
Concetta Bubici United States
Yangfu Jiang China
Gang Song China
Daniela Trisciuoglio Italy
Ming‐Hsien Chien Taiwan
Patrick Viatour United States
Arshad Rahman United States
Quansheng Zhou relative to Michitaka Ozaki Japan Michitaka Ozaki's profile →
Citations per field
00.5×1.5×
Michitaka Ozaki · 1×
Citations per year

Countries citing papers authored by Quansheng Zhou

Since Specialization
Citations

This map shows the geographic impact of Quansheng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quansheng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quansheng Zhou more than expected).

Fields of papers citing papers by Quansheng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quansheng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quansheng Zhou. The network helps show where Quansheng Zhou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Quansheng Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Quansheng Zhou Line = papers co-authored together Quansheng Zhou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20236
2 202121
3 202129
4 201618
5 201633
6 201681
7 201551
8 201421
9
Effect of ranunculus japonicus components D1 on vasculogenic mimicry of human gastric cancer cell MGC803
20132
10 20121
11 201242
12 201144
13 201068
14 200963
15 200577
16 2004101
17 200366
18 2000125
19 19968
20 199565

About Quansheng Zhou

Quansheng Zhou is a scholar working on Immunology, Cancer Research and Molecular Biology, having authored 89 papers that have together received 3.7k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (12 papers), Immunotherapy and Immune Responses (8 papers), Phagocytosis and Immune Regulation (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Erythrocyte Function and Pathophysiology (6 papers), Protease and Inhibitor Mechanisms (6 papers), Glycosylation and Glycoproteins Research (6 papers) and Chemical synthesis and alkaloids (6 papers). The work is most often cited by research in Immunology (871 citations), Cancer Research (519 citations) and Molecular Biology (2.3k citations). Quansheng Zhou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Peter J. Sims, Therese Wiedmer, Ji Zhao, Zhifei Cao, Ping Yang, Zhiwei Wang, James G. Stout, Gaochuan Zhang, Meimei Bao and Bingxue Shang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026